INS and diabetes mellitus: Perhaps the most commonly discussed issue regarding the cost of diabetes treatment is increasing insulin prices, which remain high owing to limited market competition.3 Although insulin was initially discovered and donated for the public good about a century ago, the insulin formulations sold today continue to be protected by multiple patents, including on the delivery device.4 However, insulin is not the only treatment affected by increasing costs.